Concert Pharmaceuticals (United States)
- Research works
- 106 ▲ 156% vs 2018-21
- Citations
- 796 7.5 per fractional work
- Top-10% rate
- 8.9% all institutions 10.0%
- Open access
- 48% world 40%
- International
- 8% world 18%
Not ranked overall: Concert Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Concert Pharmaceuticals (United States) work in?
In 2022-now, 60% of research at Concert Pharmaceuticals (United States) is in Health Sciences, 17% in Social Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (9%), Economics, Econometrics and Finance (7%). It does 2.3× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 18 fields, with their numbers
- Health Sciences3659.7%
- Medicine3356.0%
- Health Professions23.7%
- Social Sciences1017.2%
- Physical Sciences711.8%
- Computer Science47.3%
- Mathematics12.5%
- Engineering11.3%
- Environmental Science00.6%
- Chemistry00.1%
- Materials Science00.1%
- Life Sciences711.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 3.4×. Every wedge is a field page.
All 18 fields, with their numbers
- Economics, Econometrics and Finance3.41×4 works
- Medicine2.91×33 works
- Pharmacology, Toxicology and Pharmaceutics2.38×0 works
- Mathematics2.13×2 works
- Biochemistry, Genetics and Molecular Biology1.70×5 works
- Decision Sciences1.64×1 works
- Psychology1.50×3 works
- Health Professions1.39×2 works
- Immunology and Microbiology1.22×1 works
- Computer Science0.94×4 works
- Arts and Humanities0.39×1 works
- Social Sciences0.19×1 works
- Environmental Science0.11×0 works
- Chemistry0.09×0 works
- Business, Management and Accounting0.09×0 works
- Engineering0.08×1 works
- Materials Science0.03×0 works
- Agricultural and Biological Sciences0.01×0 works
- Economics, Econometrics and Finance 3.4×
- Medicine 2.9×
- Pharmacology, Toxicology and Pharmaceutics 2.4×
- Mathematics 2.1×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Decision Sciences 1.6×
- Psychology 1.5×
- Health Professions 1.4×
- Immunology and Microbiology 1.2×
- Computer Science 0.9×
- Arts and Humanities 0.4×
- Social Sciences 0.2×
- Environmental Science 0.1×
- Chemistry 0.1×
- Business, Management and Accounting 0.1×
- Engineering 0.1×
- Materials Science 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Concert Pharmaceuticals (United States)?
Ranked on the quality score, Scott L. Harbeson, Gillian W. Hooker and Yanina Natanzon lead among researchers whose main affiliation is Concert Pharmaceuticals (United States).
- 1
Scott L. Harbeson
United States · #1,245,524 worldwide 2.8k citations · 45 works
- 2
Gillian W. Hooker
United States · #1,262,234 worldwide 2k citations · 77 works
- 3
Yanina Natanzon
United States · #1,368,618 worldwide 990 citations · 38 works
- 4
Vivek Prabhakar Vaidya
United States · #2,440,865 worldwide 147 citations · 23 works
- 5
Vinita Uttamsingh
United States · #2,607,457 worldwide 827 citations · 26 works
- 6
Jon G. Tepsick
United States · #2,717,129 worldwide 53 citations · 21 works
- 7
Virginia M. Braman
United States · #3,026,080 worldwide 663 citations · 26 works
- 8
Virna Little
United States · #4,510,338 worldwide 202 citations · 36 works
- 9
Richard W DeClue
United States · #4,744,580 worldwide 166 citations · 32 works
Which keywords describe research at Concert Pharmaceuticals (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Precision Medicine, Clinical Trials, Targeted Therapy, Machine Learning, Chemotherapy, Healthcare, Medical Imaging and Genomic Profiling.
- Semantic Web
- Chronic Disease Management
- Data Integration
- Patient Similarity
- Cost of Care
- Prognostic Factors
- Cost-effectiveness Analysis
- Immune Checkpoint Blockade
- Depression
- Radiomics
- Radiotherapy
- Texture Analysis
- Quality of Life
- Biomarkers
- EGFR Mutations
- Treatment Guidelines
- Genomic Profiling
- Healthcare
- Targeted Therapy
- Clinical Trials
- Precision Medicine
- Machine Learning
- Chemotherapy
- Medical Imaging
- Predictive Modeling
- ALK Inhibitors
- Immunotherapy
- Big Data
- Feature Extraction
- Tumor Microenvironment
- Quantitative Analysis
- Clinical Decision Support
- Electronic Health Records
- PD-1 and PD-L1
- Health Utility Measures
- Clinical Event Prediction
- Financial Toxicity
- Breast Cancer
- Cell-Free DNA
- Metastasis
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Precision Medicine8▲ 28×5 topics
- Clinical Trials8▲ 19×6 topics
- Machine Learning8▲ 3.8×9 topics
- Targeted Therapy7▲ 53×4 topics
- Chemotherapy5▲ 12×11 topics
- Healthcare5▲ 7.7×4 topics
- Medical Imaging5▲ 16×2 topics
- Genomic Profiling5▲ 78×2 topics
- Predictive Modeling4▲ 27×2 topics
- Treatment Guidelines4▲ 31×2 topics
- ALK Inhibitors4▲ 106×1 topic
- EGFR Mutations4▲ 106×1 topic
- Immunotherapy4▲ 8.8×9 topics
- Biomarkers4▲ 8.4×4 topics
- Big Data3▲ 5.5×4 topics
- Quality of Life3▲ 3.8×8 topics
- Feature Extraction3▲ 11×3 topics
- Texture Analysis3▲ 23×2 topics
- Tumor Microenvironment3▲ 11×5 topics
- Radiotherapy3▲ 12×5 topics
- Quantitative Analysis3▲ 21×1 topic
- Radiomics3▲ 39×1 topic
- Clinical Decision Support2▲ 25×1 topic
- Depression2▲ 4.5×5 topics
- Electronic Health Records2▲ 37×2 topics
- Immune Checkpoint Blockade2▲ 34×1 topic
- PD-1 and PD-L12▲ 34×1 topic
- Cost-effectiveness Analysis2▲ 46×1 topic
- Health Utility Measures2▲ 46×1 topic
- Prognostic Factors2▲ 8.3×6 topics
- Clinical Event Prediction2▲ 44×1 topic
- Cost of Care2▲ 101×1 topic
- Financial Toxicity2▲ 101×1 topic
- Patient Similarity2▲ 44×1 topic
- Breast Cancer2▲ 11×5 topics
- Data Integration2▲ 17×3 topics
- Cell-Free DNA2▲ 28×2 topics
- Chronic Disease Management2▲ 14×3 topics
- Metastasis2▲ 7.8×5 topics
- Semantic Web2▲ 28×2 topics
Which research topics does Concert Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Lung Cancer Treatments and Mutations, Radiomics and Machine Learning in Medical Imaging, Artificial Intelligence in Healthcare and Education and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
- 3 Artificial Intelligence in Healthcare and Education Health Informatics 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 6 Machine Learning in Healthcare Artificial Intelligence 2 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 8 Cancer Genomics and Diagnostics Cancer Research 2 works
- 9 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 10 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Concert Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 156% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Concert Pharmaceuticals (United States) as a percentage of every work published that year, 0.00014% in 2024.
Fractional works of Concert Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Lexington
- Institute for Learning and Development
- Atmospheric and Environmental Research
- Inotek Pharmaceuticals (United States)
- Biostatistical Consulting (United States)
- Cubist Pharmaceuticals (United States)
- Ocean Acoustical Services and Instrumentation Systems (United States)
- Boston Collaborative Drug Surveillance Program
- Synta Pharmaceuticals (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Concert Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.